Grünenthal is an entrepreneurial, science-based pharmaceutical company specialised in pain. We are a fully integrated research & development company with a long track record of bringing innovative pain treatments and state-of-the-art technologies to patients.
Grünenthal introduced CHANGE PAIN as an international non-promotional educational initiative, to increase the knowledge of healthcare professionals with an interest in pain management and advance the management of patients suffering from acute and chronic pain.
CHANGE PAIN was launched in the UK over nine years ago and currently has more than 7,000 members. It is primarily web-based and hosts a range of CPD accredited interactive modules, learning resources, tools etc. Many international and national experts, clinical and non-clinical, have either presented CHANGE PAIN and/or have contributed to the educational content.